# Rituximab Plus Short-Duration Chemotherapy As First-Line Treatment for Follicular Non-Hodgkin’s Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rituximab-plus-short-duration-chemotherapy-as-first-line-treatment-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | John D. Hainsworth,Sharlene Litchy,Lisa H. Morrissey,Michael B. Andrews,Manuel Grimaldi,Matthew J. McCarty,F. Anthony Greco |
| Citations | 45 |
| DOI | 10.1200/jco.2005.05.004 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2144708402 |
| PMID | 15632411 |
| Type | article |
| Year | 2005 |

## Paper authors

- [Michael B. Andrews](https://scholariq.org/researchers/michael-b-andrews/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

## Paper topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Cutaneous lymphoproliferative disorders research](https://scholariq.org/topics/cutaneous-lymphoproliferative-disorders-research/)
- [Lymphadenopathy Diagnosis and Analysis](https://scholariq.org/topics/lymphadenopathy-diagnosis-and-analysis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.